Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial Testing Dose Escalated Intensity Modulated Radiotherapy for Women Treated by Breast Conservation Surgery and Appropriate Systemic Therapy for Early Breast Cancer

NCT00818051 is registered in ClinicalTrials.gov with Institute of Cancer Research, United Kingdom as lead sponsor.

NCT NCT00818051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00818051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial Testing Dose Escalated Intensity Modulated Radiotherapy for Women Treated by Breast Conservation Surgery and Appropriate Systemic Therapy for Early Breast Cancer
Lead sponsor
Institute of Cancer Research, United Kingdom
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 2008
Completion date
Not reported
Enrollment
840 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer